Tenet Healthcare Stock Forecast

Stock Price Forecast

According to 22 analysts polled by S&P Global, Tenet Healthcare stock has a consensus rating of "Strong Buy" and an average price target of $277.48. The average 1-year stock price forecast is 5.65% higher than the current stock price, while the lowest is $231 (-12.04%) and the highest is $309 (+17.66%).

Price Target: $277.48 (+5.65%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$231	$277.48	$280	$309
Change	-12.04%	+5.65%	+6.61%	+17.66%

Analyst Ratings

The average analyst rating for Tenet Healthcare stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	14	14	14	14	14	14
Buy	5	6	6	6	6	6
Hold	3	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	22	22	22	22	22	22

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Scott Fidel Goldman Sachs	Goldman Sachs	Buy Maintains $252 → $305	Buy	Maintains	$252 → $305	+16.13%	Jul 28, 2026
Jason Cassorla Guggenheim	Guggenheim	Buy Maintains $242 → $283	Buy	Maintains	$242 → $283	+7.76%	Jul 28, 2026
Michael Ha Robert W. Baird	Robert W. Baird	Hold Maintains $210 → $280	Hold	Maintains	$210 → $280	+6.61%	Jul 28, 2026
Unknown Analyst Stephens No rating	Stephens	Buy Maintains $250 → $285	Buy	Maintains	$250 → $285	+8.52%	Jul 27, 2026
A.J. Rice UBS	UBS	Buy Maintains $288 → $308	Buy	Maintains	$288 → $308	+17.28%	Jul 27, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

22.28B

from 21.31B

4.54%

from 21.31B

Revenue Next Year

22.42B

from 22.28B

0.66%

from 22.28B

EPS This Year

20.40

from 16.78

21.59%

from 16.78

EPS Next Year

19.27

from 20.40

-5.57%

from 20.40

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	19.49B	19.17B	20.56B	20.68B	21.31B	22.28B
Revenue Growth	10.46%	-1.60%	7.25%	0.54%	3.07%	4.54%
Gross Profit	7.27B	7.05B	7.82B	8.22B	8.82B	10.63B
Gross Margin	37.30%	36.76%	38.03%	39.75%	41.37%	47.70%
Operating Income	2.56B	2.49B	2.81B	3.22B	3.77B	4.24B
Net Income	914.00M	411.00M	611.00M	3.20B	1.41B	2.97B
EPS	-	-	-	-	16.78	20.40
EPS Growth	-	-	-	-	41.25%	21.59%
Forward PE	13.95	9.55	13.40	11.76	12.20	12.87
Free Cash Flow	1.56B	103.88M	903.00M	2.33B	1.68B	3.18B
No. Analysts	-	-	-	-	-	17

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	24.3B
Avg	22.3B
Low	22.0B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	13.8%
Avg	4.5%
Low	3.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	21.62
Avg	20.40
Low	18.19

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	28.8%
Avg	21.6%
Low	8.4%